Tech Company Financing Transactions

RaNA Therapeutics Funding Round

RaNA Therapeutics, operating out of Cambridge, secured $55 million from Merck Capital Ventures, The Baupost Group and Atlas Venture.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series B
Proceeds Purpose
RaNA is expanding its R&D footprint in hopes of identifying new candidates in oncology, inflammation and other diseases.

Company Information

Company Status
Private & Independent
Mailing Address
200 Sidney St. 310
Cambridge, MA 02139
Email Address
RaNA Therapeutics is a biotechnology company using its proprietary RNA upregulation platform to discover and develop highly selective epigenetic modulators of gene expression. RaNA's technology upregulates the expression of desirable genes that can prevent or treat disease.
RaNA Therapeutics LinkedIn Company Profile
Social Media
RaNA Therapeutics Company Twitter Account
Company News
RaNA Therapeutics News
RaNA Therapeutics on Facebook
RaNA Therapeutics on YouTube

Management Team

Email & Social
Chief Executive Officer
Ronald Renaud
  Ronald Renaud LinkedIn Profile  Ronald Renaud Twitter Account  Ronald Renaud News  Ronald Renaud on Facebook
VP - Bus. Development
Brian Fenton
  Brian Fenton LinkedIn Profile  Brian Fenton Twitter Account  Brian Fenton News  Brian Fenton on Facebook



Browse more venture capital transactions:

Prev: 7/23/2015: 1DocWay venture capital transaction
Next: 7/23/2015: Leadspace venture capital transaction


Share this article


News on VC Transactions

We do our best to report on every notable VC transaction. VC transactions on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary